Citations

Clear

2511 citation(s) found for "Yang, Yu".

Abstract C62: Attacking the most downstream “gatekeeper” signaling module in the oncogenic ERBB/K-RAS signaling pathway to block tumorigenesis and metastasis in human cancer
Bian, Minglei, Zheleva, Vasilena, Urban, Zena M., Njogu, Monicah M., Odanga, Justin J. , Isbell, Andrew J., Schmidt, Rebecca L., Takahashi, Rie , Perry, Roger R , Smyrk, Thomas C. , Petersen, Gloria M. , Liao, Yang , Gao, Xiaofei , Hoefer, Richard A. , Tang, Amy

Mayo Clinic

Cancer Research | August 14, 2014 | Volume: 73 | Issue: 19_Supplement | Pages: C62-C62

10.1158/1538-7445.fbcr13-c62 Get It

Abstract Hyperactive ERBB/K-RAS signaling is a major menace that drives aggressive tumor growth and metastasis in human cancer. Currently, there are no effective ways to treat late-stage and relapsed human cancers that have oncogenic ERBB/K-RAS mutations that often confer drug resistance, aggressive tumor growth, systemic metastasis, and poor clinical outcome. Therefore, finding novel approaches and new drug targets to inhibit oncogenic ERBB/K-RAS activation is an urgent goal and the major challenge in cancer therapy and treatment. Instead of targeting an upstream signaling module such as EGFR/HER2/KRAS/B-RAF, we targeted the most downstream signaling module in the EGFR/HER2/K-RAS pathway called the SIAH-dependent proteolytic machinery. SIAHs are the human homologs of Seven-In-Absentia (SINA), an evolutionarily conserved RING E3 ligase, an essential downstream signaling module and a critical “gatekeeper” required for proper EGFR/HER2/K-RAS/B-RAF signal transduction. Guided by the insights and fundamental principles learned from the Drosophila RAS signaling pathway, we conducted preclinical studies to dissect SIAH function in the context of ERBB/K-RAS-mediated tumorigenesis and metastasis in human cancer cells and human cancer biospecimens. We found that (1) SIAH is a great prognostic and predictive biomarker for human cancer, and (2) inhibiting SIAH function is highly effective to block tumorigenesis and metastasis against the well-established, late-stage and metastatic pancreatic cancer and triple negative breast cancer (TNBC). These findings demonstrate that SIAH is an attractive and logical new therapeutic target for novel anti-ERBB/oncogenic K-RAS and anticancer therapy in human cancer. Through our work, SIAH has emerged as a new and effective drug target against oncogenic ERBB/K-RAS activation in human cancer cells. Using anti-SIAH molecules to block K-RAS signaling in human cancer is an excellent example of science going “from the bench (basic research in fruit flies) to the bedside (preclinical studies and ultimately clinical trials)”. As a highly evolutionarily conserved E3 ligase and the most downstream “gatekeeper” of EGFR/HER2/K-RAS/B-RAF signaling pathway, SIAH is uniquely and logically positioned to become a next-generation anti-ERBB/anti-K-RAS drug target. Our preclinical studies have demonstrated that “SIAH-dependent proteolysis” is indeed an Achilles' heel in human cancer. Knowledge gained from our study has great promise and immediate translational values. Anti-SIAH-based small molecule inhibitors may aid in expanding our arsenal of novel anticancer therapies. By attacking the oncogenic ERBB/K-RAS/B-RAF pathway using multi-pronged synergistic inhibitions at upstream (EGFR/HER2 membrane receptors), midstream (K-RAS/B-RAF/MEK/mTOR) and downstream (SIAH E3 ligase) signaling modules in parallel, we will be in a position to control the late-stage, relapsed and metastatic human cancers. If successful, we hope to develop anti-SIAH-based therapy and translate our findings to the cancer clinics to treat cancer patients with metastatic diseases in the near future. Citation Format: Minglei Bian, Yang Liao, Vasilena Zheleva, Xiaofei Gao, Zena M. Urban, Monicah M. Njogu, Justin J. Odanga, Andrew J. Isbell, Rebecca L. Schmidt, Rie Takahashi, Roger R. Perry, Richard A. Hoefer, Thomas C. Smyrk, Gloria M. Petersen, Amy H. Tang. Attacking the most downstream “gatekeeper” signaling module in the oncogenic ERBB/K-RAS signaling pathway to block tumorigenesis and metastasis in human cancer. [abstract]. In: Proceedings of the Third AACR International Conference on Frontiers in Basic Cancer Research; Sep 18-22, 2013; National Harbor, MD. Philadelphia (PA): AACR; Cancer Res 2013;73(19 Suppl):Abstract nr C62.
Understanding Cardiac Sarcomere Assembly With Zebrafish Genetics
Yang, Jingchun , Shih, Yu-Huan, Xu, Xiaolei

Mayo Clinic

The Anatomical Record | August 14, 2014 | Volume: 297 | Issue: 9 | Pages: 1681-1693

10.1002/ar.22975 | PMID 25125181 Get It

ABSTRACTMutations in sarcomere genes have been found in many inheritable human diseases, including hypertrophic cardiomyopathy. Elucidating the molecular mechanisms of sarcomere assembly shall facilitate understanding of the pathogenesis of sarcomere‐based cardiac disease. Recently, biochemical and genomic studies have identified many new genes encoding proteins that localize to the sarcomere. However, their precise functions in sarcomere assembly and sarcomere‐based cardiac disease are unknown. Here, we review zebrafish as an emerging vertebrate model for these studies. We summarize the techniques offered by this animal model to manipulate genes of interest, annotate gene expression, and describe the resulting phenotypes. We survey the sarcomere genes that have been investigated in zebrafish and discuss the potential of applying this in vivo model for larger‐scale genetic studies. Anat Rec, 297:1681–1693, 2014. © 2014 Wiley Periodicals, Inc.
Targeting aPKC disables oncogenic signaling by both the EGFR and the proinflammatory cytokine TNFα in glioblastoma
Kusne, Yael , Silva, Eugenio Antonio Carrera , Perry, Anthony S. , Mandell, Edward K., Dietrich, Justin , Errasti, Andrea Emilse , Gibbs, Daniel , Berens, Michael E. , Loftus, Joseph C. , Hulme, Christopher , Aldape, Kenneth , Sanai, Nader , Rothlin, Carla V. , Ghosh, Sourav , Rushing, Elisabeth Jane , Yang, Weiwei , Lu, Zhimin , Berens, Michael E

Mayo Clinic

Science Signaling | August 12, 2014 | Volume: 7 | Issue: 338 | Pages: No page available

10.1126/scisignal.2005196 | PMID 25118327 Get It

Targeting a kinase common to both the EGFR and TNFα signaling pathways may prevent drug resistance in glioblastoma.
TGF‐β signaling regulates fibrotic expression and activity in carpal tunnel syndrome
Gingery, Anne , Yang, Tai‐Hua , Passe, Sandra, An, Kai‐Nan, Zhao, Chunfeng , Amadio, Peter C. , An, Kai‐Nan , Gingery, Anne

Mayo Clinic

Journal of Orthopaedic Research | July 30, 2014 | Volume: 32 | Issue: 11 | Pages: 1444-1450

10.1002/jor.22694 | PMID 25073432 Get It

ABSTRACTFibrosis of the subsynovial connective tissue (SSCT) is a predominant feature of carpal tunnel syndrome (CTS). While the nature of CTS has been extensively studied, little is known about the etiology of this disease. We investigated SSCT tissue from patients with CTS and control subjects using fibrosis arrays and cell culture analysis. Twofold changes in fibrotic gene expression were found in multiple genes from patient SSCT using fibrosis arrays. This data was confirmed via qRT‐PCR on a subset of genes; collagen I (Col1), collagen III (Col3), connective tissue growth factor (CTGF), transforming growth factor β (TGF‐β), and SMAD3 (P < 0.05) which significantly corroborate the fold changes found in the fibrosis arrays. To further explore the nature of SSCT fibrosis, cells were isolated from patient and control tissue. Col1, Col3, TGF‐β, and SMAD3 were highly expressed in patient SSCT fibroblasts as compared to control (P < 0.05). Further, fibrotic genes expression was decreased by inhibiting TGF‐β receptor I (TβRI) activity (P < 0.05). TGF‐β second messenger SMAD activity was significantly activated in SSCT fibroblasts from patients and this activation was abrogated by inhibiting TβRI signaling (P < 0.05). These findings suggest that blocking TGF‐β signaling may be an important therapeutic approach to treating the underlying fibrosis of SSCT in CTS patients. © 2014 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res 32:1444–1450, 2014.
Reply
Yang, Ju Dong , Guy, Cynthia D. , Suzuki, Ayako , Yang, Ju Dong , Suzuki, Ayako

Mayo Clinic

Hepatology | July 26, 2014 | Volume: 61 | Issue: 3 | Pages: 1094-1094

10.1002/hep.27335 | PMID 25066967 Get It

Spillover of Cytokines and Reactive Oxygen Species in Ventilator-Induced Lung Injury Associated With Inflammation and Apoptosis in Distal Organs
Liu, Yung-Yang , Chiang, Chi-Huei, Chuang, Chiao–Hui, Liu, Shiou-Ling, Jheng, Yi‐Han, Ryu, Jay H. , Chiang, Chi‐Huei, Ryu, Jay H

Mayo Clinic

Respiratory Care | July 23, 2014 | Volume: 59 | Issue: 9 | Pages: 1422-1432

10.4187/respcare.02992 | PMID 25053831 Get It

BACKGROUND: The mechanism between ventilator-induced lung injury (VILI) and multiple organ injury is unclear. The aim of our study was to investigate the mechanisms of VILI-induced distal organ injury. METHODS: VILI was induced in rat lungs with high tidal volume (V T ) ventilation of 40 mL/kg for 6 h. Rats with low V T ventilation of 6 mL/kg served as controls. Inflammatory and apoptotic indices in lung and distal organs were assessed. RESULTS: VILI increased lung weight, airway pressure, inflammation, and apoptotic pathologic changes without hemodynamic changes. The white blood cell count and the levels of H 2 O 2 , interleukin-1β (IL-1β), tumor necrosis factor alpha, and macrophage inflammatory protein-2 in bronchoalveolar lavage fluid were higher in the VILI group compared with the control group. H 2 O 2 , IL-1β, and tumor necrosis factor alpha in blood from the left ventricle were up-regulated. H 2 O 2 , IL-1β, tumor necrosis factor alpha, macrophage inflammatory protein-2, c-Jun N-terminal kinase, p38, nuclear factor kappa B, and caspase-3 in lung, heart, liver, and kidney tissues in the VILI group were up-regulated. Furthermore, the apoptotic score for the kidneys was higher than those for other distal organs in the VILI group. CONCLUSIONS: High V T ventilation induces VILI and is associated with inflammation and apoptosis in distal organs. Up-regulation of reactive oxygen species and cytokines in VILI is associated with systemic inflammatory responses. Kidney tissue appears to be more vulnerable than heart and liver tissues following VILI.
Clinical utility of complement biomarkers in the diagnosis and treatment of acute thrombotic microangiopathies
Yui, Jennifer , Holers, V. Michael , Yang, Shangbin, Wu, Haifeng, Cataland, Spero R.

Mayo Clinic

British Journal of Haematology | July 8, 2014 | Volume: 167 | Issue: 5 | Pages: 697-698

10.1111/bjh.13025 | PMID 25040791 Get It

Effect of Aging on Human Circulatory System in Normotensive Healthy Subjects
Lin, Mike, Lin, Shoa-Lin, Wang, Kuei-Liang, Kuo, Hsien‐Wen , Tak, Tahir

Mayo Clinic

International Journal of Angiology | June 9, 2014 | Volume: 23 | Issue: 04 | Pages: 233-242

10.1055/s-0034-1374735 | PMID 25484554 Get It

Pheochromocytoma and Paraganglioma: An Endocrine Society Clinical Practice Guideline
Lenders, Jacques W.M. , Duh, Quan‐Yang , Eisenhofer, Graeme, Gimenez‐Roqueplo, Anne‐Paule , Grebe, Stefan K., Murad, M. Hassan , Eisenhofer, Graeme, Naruse, Mitsuhide , Pacák, Karel , Young, William F. , Murad, M Hassan , Gimenez-Roqueplo, Anne-Paule

Mayo Clinic

The Journal of Clinical Endocrinology & Metabolism | June 3, 2014 | Volume: 99 | Issue: 6 | Pages: 1915-1942

10.1210/jc.2014-1498 | PMID 24893135 Get It